HA: Hemagglutinin
Protein in Influenza A virus that 4 drugs act on.
- Drugs that act on it: 4
- Approved: 0
- In phases 1 to 3: 4
- Sponsors: 3
Who is on it, and how far along
Every drug ChEMBL records acting on HA, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
- Antibody 1
- Other 2
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- MedImmune LLC125%
- Roche125%
- Visterra, Inc.125%
| Trial | Drug | Phase | Status | Lead sponsor | First posted |
|---|---|---|---|---|---|
| Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis | Umifenovir | Not applicable | Recruiting | Zheng Liu | Jun 17, 2024 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3559640, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets